Barclays lowered its price target while CMS determined excessive premiums for Centene Corporation.
2 reports, 2 independent
Updated Sep 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays lowered its price target while CMS determined excessive premiums for Centene Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
-
Centene Corporation
American multinational healthcare company
-
Centers for Medicare and Medicaid Services
United States federal agency
Nothing else this week.
Related events
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
- On July 11, 2025, a rating action was taken on Hewlett Packard Enterprise and Barclays, including raising the price target and maintaining an overweight rating.
- Centene Corporation is involved in government-sponsored healthcare plans, including Medicaid and Medicare Part D.
- Barclays adjusted its price target for Labcorp on June 24, 2025.
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.
Coverage
Newest first; wire copies grouped- StockStoryWhy Centene (CNC) Stock Is Down Today Shares of health coverage company Centene (NYSE:CNC) fell 5.4% in the afternoon session after Barclays significantly lowered its price target on the stock. Barcl
- Yahoo FinanceHealth insurance companies have a problem — people are using their plans more When medical insurance provider Centene (CNC) opened its books to investors on Friday, the company reported a surprising